Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AILERON THERAPEUTICS INC | 393,000 | reported | 30 Mar 2022 | tx 6+1,736,000 |
| Oncorus, Inc. | 51,000 | reported | 25 May 2022 | tx 8+274,000 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 May 2022 | PURCHASE | Oncorus, Inc. | 3,777 | 1.20 USD | |
| 20 May 2022 | PURCHASE | Oncorus, Inc. | 1,610 | 1.20 USD | |
| 19 May 2022 | PURCHASE | Oncorus, Inc. | 5,000 | 1.29 USD | |
| 17 May 2022 | PURCHASE | Oncorus, Inc. | 1 | 1.20 USD | |
| 12 May 2022 | PURCHASE | Oncorus, Inc. | 14,094 | 1.08 USD | |
| 13 May 2022 |
| PURCHASE |
| Oncorus, Inc. |
| 3,898 |
| 1.15 USD |
| 16 May 2022 | PURCHASE | Oncorus, Inc. | 20,620 | 1.18 USD |
| 10 May 2022 | GRANT_AWARD | Oncorus, Inc. | 225,000 | 0.00 USD | deriv |
| 22 Mar 2022 | GRANT_AWARD | AILERON THERAPEUTICS INC | 393,000 | 0.00 USD | deriv |
| 15 Jun 2021 | GRANT_AWARD | AILERON THERAPEUTICS INC | 600,000 | 0.00 USD | deriv |
| 23 Jun 2020 | GRANT_AWARD | AILERON THERAPEUTICS INC | 91,000 | 0.00 USD | deriv |
| 31 Jan 2020 | GRANT_AWARD | AILERON THERAPEUTICS INC | 200,000 | 0.00 USD | deriv |
| 15 Apr 2019 | GRANT_AWARD | AILERON THERAPEUTICS INC | 59,000 | 0.00 USD | deriv |